About this event

  • Date and time Wed 10 Oct 2018 from 5:30pm to 8:00pm
  • Location Royal Society of Medicine
  • Organised by Rheumatology and Rehabilitation

We are experiencing major advances in our understanding of the human microbiome and its role in health and disease.

This growing knowledge on the diversity of microbes and their part and impact on immune-driven pathophysiological processes could unravel new mechanistic pathways linking the microbiome with certain diseases.

This knowledge could yield novel insights and inform the development of new therapies.

The evening session will cover the role of the microbiome in autoimmunity and non-communicable diseases, discuss the use and role of metabolite profiling and present disease-specific links with the microbiome along with exciting new research initiatives on the subject.

You will learn:

  • The role of the microbiome in health and in disease, with a focus on autoimmunity and non-communicable diseases.
  • What metabolite profiling is and what it may be used for.
  • Links between the microbiome and rheumatoid arthritis.


View the programme

Registration, tea and coffee
Welcome and introduction

Dr Elena Nikiphorou, President, Rheumatology & Rehabilitation Section, Royal Society of Medicine

The role of the microbiome in autoimmunity and non-communicable diseases

Professor Julian Marchesi, Professor of Human Microbiome Research and Professor of Digestive Diseases, Imperial College London and Cardiff University

Metabolic profiling: What is it and what for?

Dr Jonathan Swann, Reader in Human Development and Microbiomics, Imperial College London

Rheumatoid arthritis links to the microbiome

Professor Frances Williams, Professor of Genomic Epidemiology, King’s College London and Honorary Consultant in Rheumatology, Guy’s and St Thomas’ NHS Foundation Trust

Panel discussion
Close of meeting


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom